New diabetes clinical trial: A Study of LY3437943 in Participants With Type 2 Diabetes
Published on: April 30, 2021 at 09:30PM
Condition: Type 2 Diabetes
Interventions: Drug: LY3437943; Drug: Dulaglutide; Drug: Placebo
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3vpAsiS
Condition: Type 2 Diabetes
Interventions: Drug: LY3437943; Drug: Dulaglutide; Drug: Placebo
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3vpAsiS
Comments
Post a Comment